2,691
Views
4
CrossRef citations to date
0
Altmetric

References

  • Lim ML, Wallace MR. Infectious diarrhea in history. Infect Dis Clin North Am. 2004;18(2):261–274.
  • Bishop RF, Davidson GP, Holmes IH, et al. Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis. Lancet. 1973;2(7841):1281–1283.
  • Flewett TH, Bryden AS, Davies H, et al. Relation between viruses from acute gastroenteritis of children and newborn calves. Lancet. 1974;2(7872):61–63.
  • International Committee on Taxonomy of Viruses. 2021. https://talk.ictvonline.org/taxonomy/. [Accessed: 2021 04 21].
  • Lundgren O, Svensson L. Pathogenesis of rotavirus diarrhea. Microbes Infect. 2001;3(13):1145–1156.
  • Suzuki T, Inoue D. Full genome-based genotyping system for rotavirus H and detection of potential gene recombination in nonstructural protein 3 between porcine rotavirus H and rotavirus C. J Gen Virol. 2018;99(12):1582–1589.
  • Flores PS, Costa FB, Amorim AR, et al. Rotavirus A, C, and H in Brazilian pigs: potential for zoonotic transmission of RVA. J Vet Diagn Invest. 2021;33(1):129–135.
  • Sadiq A, Bostan N, Yinda KC, et al. Rotavirus: genetics, pathogenesis and vaccine advances. Rev Med Virol. 2018;28(6):e2003.
  • Rotavirus classification working group. List of Accepted Genotypes. https://rega.kuleuven.be/cev/viralmetagenomics/virus-classification/rcwg. [ Accessed: 26.03.2021].
  • Yen C, Cortese MM. 216 - Rotaviruses. Principles and Practice of Pediatric Infectious Diseases. (Fourth. Long SS, editor. Content Repository Only!. Edinburgh ; New York : Elsevier Churchill Livingstone:2012. p. 1094–7.e3.
  • Matthijnssens J, Heylen E, Zeller M, et al. Phylodynamic analyses of rotavirus genotypes G9 and G12 underscore their potential for swift global spread. Mol Biol Evol. 2010;27(10):2431–2436.
  • Ramig RF. Pathogenesis of Intestinal and Systemic Rotavirus Infection. J Virol. 2004;78(19):10213–10220.
  • Korsman SNJ, Van Zyl GU, Nutt L, et al. Gastrointestinal illness. In: Korsman SNJ, Van Zyl GU, Nutt L, et al.editors. Virology. Edinburgh: Churchill Livingstone; 2012. p. 106–107.
  • Parashar UD, Hummelman EG, Bresee JS, et al. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis. 2003;9(5):565–572.
  • Parashar UD, Gibson CJ, Bresee JS, et al. Rotavirus and severe childhood diarrhea. Emerg Infect Dis. 2006;12(2):304–306.
  • Troeger C, Khalil IA, Rao PC, et al. Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea Among Children Younger Than 5 Years. JAMA Pediatr. 2018;172(10): 958–965.
  • World Health Organization. Rotavirus vaccines WHO position paper: January 2013 - Recommendations. Vaccine. 2013;31(52):6170–6171.
  • Hartling L, Bellemare S, Wiebe N, et al. Oral versus intravenous rehydration for treating dehydration due to gastroenteritis in children. Cochrane Database Syst Rev. 2006;2006(3):CD004390.
  • Lamberti LM, Walker CL, Chan KY, et al. Oral zinc supplementation for the treatment of acute diarrhea in children: a systematic review and meta-analysis. Nutrients. 2013;5(11):4715–4740.
  • Groome MJ, Moon SS, Velasquez D, et al. Effect of breastfeeding on immunogenicity of oral live-attenuated human rotavirus vaccine: a randomized trial in HIV-uninfected infants in Soweto, South Africa. Bull World Health Organ. 2014;92(4):238–245.
  • Burke RM, Tate JE, Kirkwood CD, et al. Current and new rotavirus vaccines. Curr Opin Infect Dis. 2019;32(5):435–444.
  • Burnett E, Parashar UD, Tate JE. Real-world effectiveness of rotavirus vaccines, 2006-19: a literature review and meta-analysis. Lancet Glob Health. 2020;8(9):e1195–e1202.
  • World Health Organization. Meeting of the immunization Strategic Advisory Group of Experts, April 2009 – conclusions and recommendations. Wkly Epidemiol Rec. 2009;84(23):213-236.
  • World Health Organization. Meeting of the immunization Strategic Advisory Group of Experts, November 2006 – conclusions and recommendations. Wkly Epidemiol Rec. 2007;1-2(82):1–16.
  • International Vaccine Access Center (IVAC). VIEW-hub Global Vaccine Introduction Report. 2020. https://www.jhsph.edu/ivac/. [Accessed: 2020 12 16].
  • Troeger C, Blacker BF, Khalil IA, et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 2018;18(11):1211–1228.
  • Thirteenth International Rotavirus Symposium. Expanding Rotavirus Vaccine Impact: Improving Coverage and Equity [Internet]. 2018. https://www.sabin.org/sites/sabin.org/files/resources/rota2018report_final.pdf. [Accessed: 2021 03 27].
  • Troeger C, Forouzanfar M, Rao PC, et al. Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect Dis. 2017;17(9):909–948.
  • Tate JE, Burton AH, Boschi-Pinto C, et al. Global, regional, and national estimates of rotavirus mortality in children <5 years of age, 2000-2013. Clin Infect Dis. 2016;62(Suppl 2):S96–s105.
  • Buchy P, Chen J, Zhang X-H, et al. A review of rotavirus vaccine use in Asia and the Pacific regions: challenges and future prospects. Expert Rev Vaccines. 2021.
  • Armah GE, Sow SO, Breiman RF, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;376(9741):606–614.
  • Madhi S, Cunliffe N, Steele D, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. New Engl J Med. 2010;362(4):289–298.
  • Zaman K, Dang DA, Victor JC, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;376(9741):615–623.
  • Leshem E, Moritz RE, Curns AT, et al. Rotavirus vaccines and health care utilization for diarrhea in the United States (2007–2011). Pediatrics. 2014;134(1):15–23.
  • Rha B, Tate JE, Payne DC, et al. Effectiveness and impact of rotavirus vaccines in the United States - 2006-2012. Expert Rev Vaccines. 2014;13(3):365–376.
  • Vesikari T, Karvonen A, Prymula R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet. 2007;370(9601):1757–1763.
  • Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354(1):23–33.
  • Levine MM. Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine. BMC Biol. 2010;8(1):129.
  • Clark A, van Zandvoort K, Flasche S, et al. Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials. Lancet Infect Dis. 2019;19(7): 717–727.
  • Lamberti LM, Ashraf S, Walker CL, et al. A Systematic Review of the Effect of Rotavirus Vaccination on Diarrhea Outcomes Among Children Younger Than 5 Years. Pediatr Infect Dis J. 2016;35(9):992–998.
  • Desselberger U. Differences of Rotavirus Vaccine Effectiveness by Country: likely Causes and Contributing Factors. Pathogens. 2017;6(4):65.
  • Soares-Weiser K, Bergman H, Henschke N, et al. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev. 2019;3(3):Cd008521.
  • Lopman BA, Pitzer VE, Sarkar R, et al. Understanding reduced rotavirus vaccine efficacy in low socio-economic settings. PLOS ONE. 2012;7(8):e41720.
  • Steele AD, Victor JC, Carey ME, et al. Experiences with rotavirus vaccines: can we improve rotavirus vaccine impact in developing countries? Hum Vaccin Immunother. 2019;15(6): 1215–1227.
  • Gruber JF, Hille DA, Liu GF, et al. Heterogeneity of rotavirus vaccine efficacy among infants in developing countries. Pediatr Infect Dis J. 2017;36(1):72–78.
  • Katona P, Katona-Apte J. The Interaction between Nutrition and Infection. Clin Inf Dis. 2008;46(10):1582–1588.
  • Black RE, Victora CG, Walker SP, et al. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet. 2013;382(9890):427–451.
  • Prendergast AJ. Malnutrition and vaccination in developing countries. Philos Trans R Soc Lond B Biol Sci. 2015;370(1671):20140141.
  • Hoest C, Seidman JC, Pan W, et al. Evaluating associations between vaccine response and malnutrition, gut function, and enteric infections in the MAL-ED cohort study: methods and challenges. Clin Infect Dis. 2014;59(Suppl4):S273–9.
  • Parker EP, Ramani S, Lopman BA, et al. Causes of impaired oral vaccine efficacy in developing countries. Future Microbiol. 2018;13(1):97–118.
  • Young GP, Mortimer EK, Gopalsamy GL, et al. Zinc deficiency in children with environmental enteropathy-development of new strategies: report from an expert workshop. Am J Clin Nutr. 2014;100(4):1198–1207.
  • Fraker PJ, King LE. Reprogramming of the immune system during zinc deficiency. Annu Rev Nutr. 2004;24:277–298.
  • Church JA, Parker EP, Kirkpatrick BD, et al. Interventions to improve oral vaccine performance: a systematic review and meta-analysis. Lancet Infect Dis. 2019;19(2): 203–214.
  • Bosomprah S, Beach LB, Beres LK, et al. Findings from a comprehensive diarrhoea prevention and treatment programme in Lusaka, Zambia. BMC Public Health. 2016;16:475.
  • Colgate ER, Haque R, Dickson DM, et al. Delayed dosing of oral rotavirus vaccine demonstrates decreased risk of rotavirus gastroenteritis associated with serum zinc: a randomized controlled trial. Clin Infect Dis. 2016;63(5):634–641.
  • Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol. 2008;8(9):685–698.
  • Surman SL, Penkert RR, Jones BG, et al. Vitamin supplementation at the time of immunization with a cold-adapted influenza virus vaccine corrects poor mucosal antibody responses in mice deficient for vitamins A and D. Clin Vaccine Immunol. 2016;23(3):219–227.
  • Chattha KS, Kandasamy S, Vlasova AN, et al. Vitamin A deficiency impairs adaptive B and T cell responses to a prototype monovalent attenuated human rotavirus vaccine and virulent human rotavirus challenge in a gnotobiotic piglet model. PLOS ONE. 2013;8(12):e82966.
  • Zhao Y, Yu B, Mao X, et al. Dietary vitamin D supplementation attenuates immune responses of pigs challenged with rotavirus potentially through the retinoic acid-inducible gene I signalling pathway. Br J Nutr. 2014;112(3):381–389.
  • Kandasamy S, Chattha KS, Vlasova AN, et al. Prenatal vitamin A deficiency impairs adaptive immune responses to pentavalent rotavirus vaccine (RotaTeq®) in a neonatal gnotobiotic pig model. Vaccine. 2014;32(7):816–824.
  • Vlasova AN, Chattha KS, Kandasamy S, et al. Prenatally acquired vitamin A deficiency alters innate immune responses to human rotavirus in a gnotobiotic pig model. J Immunol. 2013;190(9):4742–4753.
  • Guerrant RL, DeBoer MD, Moore SR, et al. The impoverished gut--a triple burden of diarrhoea, stunting and chronic disease. Nat Rev Gastroenterol Hepatol. 2013;10(4):220–229.
  • Jensen KJ, Ndure J, Plebanski M, et al. Heterologous and sex differential effects of administering vitamin A supplementation with vaccines. Trans R Soc Trop Med Hyg. 2015;109(1):36–45.
  • Durandy A. Ontogeny of the immune system. Transfus Med Hemother. 2003;30(5):222–227.
  • Mwila K, Chilengi R, Simuyandi M, et al. Contribution of maternal immunity to decreased rotavirus vaccine performance in low- and middle-income countries. Clin Vaccine Immunol. 2017;24(1):e00405–16.
  • Chan J, Nirwati H, Triasih R, et al. Maternal antibodies to rotavirus: could they interfere with live rotavirus vaccines in developing countries? Vaccine. 2011;29(6):1242–1247.
  • Becker-Dreps S, Vilchez S, Velasquez D, et al. Rotavirus-specific IgG antibodies from mothers’ serum may inhibit infant immune responses to the pentavalent rotavirus vaccine. Pediatr Infect Dis J. 2015;34(1):115–116.
  • Appaiahgari MB, Glass R, Singh S, et al. Transplacental rotavirus IgG interferes with immune response to live oral rotavirus vaccine ORV-116E in Indian infants. Vaccine. 2014;32(6):651–656.
  • Moon SS, Groome MJ, Velasquez DE, et al. Prevaccination rotavirus Serum IgG and IgA are associated with lower immunogenicity of live, oral human rotavirus vaccine in South African infants. Clin Infect Dis. 2016;62(2):157–165.
  • Chen MY, Kirkwood CD, Bines J, et al. Rotavirus specific maternal antibodies and immune response to RV3-BB neonatal rotavirus vaccine in New Zealand. Hum Vaccin Immunother. 2017;13(5):1126–1135.
  • Gruber JF, Gruber LM, Weber RP, et al. Rotavirus vaccine schedules and vaccine response among infants in low- and middle-income countries: a systematic review. Open Forum Infect Dis. 2017;4(2):ofx066.
  • Siegrist C-A, Aspinall R. B-cell responses to vaccination at the extremes of age. Nat Rev Immunol. 2009;9(3):185–194.
  • Bines JE, At Thobari J, Satria CD, et al. Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from Birth. New Engl J Med. 2018;378(8):719–730.
  • Rongsen-Chandola T, Strand TA, Goyal N, et al. Effect of withholding breastfeeding on the immune response to a live oral rotavirus vaccine in North Indian infants. Vaccine. 2014;32(Suppl 1):A134–9.
  • Goveia MG, DiNubile MJ, Dallas MJ, et al. Efficacy of pentavalent human-bovine (WC3) reassortant rotavirus vaccine based on breastfeeding frequency. Pediatr Infect Dis J. 2008;27(7):656–658.
  • Vesikari T, Prymula R, Schuster V, et al. Efficacy and immunogenicity of live-attenuated human rotavirus vaccine in breast-fed and formula-fed European infants. Pediatr Infect Dis J. 2012;31(5):509–513.
  • Rennels MB, Wasserman SS, Glass RI, et al. Comparison of immunogenicity and efficacy of rhesus rotavirus reassortant vaccines in breastfed and nonbreastfed children. US Rotavirus Vaccine Efficacy Group. Pediatrics. 1995;96(6):1132–1136.
  • Caddy SL, Vaysburd M, Wing M, et al. Intracellular neutralisation of rotavirus by VP6-specific IgG. PLoS Pathog. 2020;16(8):e1008732.
  • Imbert-Marcille BM, Barbé L, Dupé M, et al. A FUT2 gene common polymorphism determines resistance to rotavirus A of the P[8] genotype. J Infect Dis. 2014;209(8):1227–1230.
  • Hu L, Crawford SE, Czako R, et al. Cell attachment protein VP8* of a human rotavirus specifically interacts with A-type histo-blood group antigen. Nature. 2012;485(7397):256–259.
  • Ramani S, Hu L, Venkataram Prasad BV, et al. Diversity in rotavirus-host glycan interactions: a “sweet” spectrum. Cell Mol Gastroenterol Hepatol. 2016;2(3):263–273.
  • Nordgren J, Sharma S, Bucardo F, et al. Both Lewis and secretor status mediate susceptibility to rotavirus infections in a rotavirus genotype-dependent manner. Clin Infect Dis. 2014;59(11):1567–1573.
  • Kazi AM, Cortese MM, Yu Y, et al. Secretor and salivary ABO blood group antigen status predict rotavirus vaccine take in infants. J Infect Dis. 2017;215(5):786–789.
  • Trang NV, Vu HT, Le NT, et al. Association between Norovirus and rotavirus infection and histo-blood group antigen types in Vietnamese children. J Clin Microbiol. 2014;52(5):1366–1374.
  • Chang JG, Yang TY, Liu TC, et al. Molecular analysis of secretor type alpha(1,2)-fucosyltransferase gene mutations in the Chinese and Thai populations. Transfusion. 1999;39(9):1013–1017.
  • Yu LC, Chu CC, Chan YS, et al. Polymorphism and distribution of the Secretor alpha(1,2)-fucosyltransferase gene in various Taiwanese populations. Transfusion. 2001;41(10):1279–1284.
  • Kambhampati A, Payne DC, Costantini V, et al. Host genetic susceptibility to enteric viruses: a systematic review and metaanalysis. Clin Infect Dis. 2016;62(1):11–18.
  • Emperador DM, Velasquez DE, Estivariz CF, et al. Interference of monovalent, bivalent, and trivalent oral poliovirus vaccines on monovalent rotavirus vaccine immunogenicity in rural Bangladesh. Clin Infect Dis. 2016;62(2):150–156.
  • Patel M, Steele AD, Parashar UD. Influence of oral polio vaccines on performance of the monovalent and pentavalent rotavirus vaccines. Vaccine. 2012;30(Suppl 1):A30–5.
  • Hens N, Aerts M, Faes C, et al. Seventy-five years of estimating the force of infection from current status data. Epidemiol Infect. 2010;138(6):802–812.
  • Muench H. Derivation of Rates from Summation Data by the Catalytic Curve. J Am Stat Assoc. 1934;29(185):25–38.
  • Steele AD, Madhi SA, Cunliffe NA, et al. Incidence of rotavirus gastroenteritis by age in African, Asian and European children: relevance for timing of rotavirus vaccination. Hum Vaccin Immunother. 2016;12(9):2406–2412.
  • Payment P, Morin É. Minimal infective dose of the OSU strain of porcine rotavirus. Arch Virol. 1990;112(3):277–282.
  • Velázquez FR, Matson DO, Calva JJ, et al. Rotavirus infection in infants as protection against subsequent infections. N Engl J Med. 1996;335(14):1022–1028.
  • Zaman K, Sack DA, Neuzil KM, et al. Effectiveness of a live oral human rotavirus vaccine after programmatic introduction in Bangladesh: a cluster-randomized trial. PLoS Med. 2017;14(4):e1002282.
  • Bennett A, Nagelkerke N, Heinsbroek E, et al. Estimating the incidence of rotavirus infection in children from India and Malawi from serial anti-rotavirus IgA titres. PLOS ONE. 2017;12(12):e0190256.
  • Cherian T, Wang S, Mantel C. Rotavirus vaccines in developing countries: the potential impact, implementation challenges, and remaining questions. Vaccine. 2012;30(Suppl 1):A3–6.
  • Vojtek I, Buchy P, Doherty TM, et al. Would immunization be the same without cross-reactivity? Vaccine. 2019;37(4):539–549.
  • Kang G, Desai R, Arora R, et al. Diversity of circulating rotavirus strains in children hospitalized with diarrhea in India, 2005–2009. Vaccine. 2013;31(27):2879–2883.
  • Santos N, Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol. 2005;15(1):29–56.
  • Gupta S, Chaudhary S, Bubber P, et al. Epidemiology and genetic diversity of group A rotavirus in acute diarrhea patients in pre-vaccination era in Himachal Pradesh, India. Vaccine. 2019;37(36):5350–5356.
  • Todd S, Page NA, Steele AD, et al. Rotavirus strain types circulating in Africa: review of studies published during 1997–2006. J Infect Dis. 2010;202(Suppl):S34–S42.
  • Kirkwood CD. Genetic and antigenic diversity of human rotaviruses: potential impact on vaccination programs. J Infect Dis. 2010;202(Suppl):S43–8.
  • Athiyyah AF, Utsumi T, Wahyuni RM, et al. Molecular epidemiology and clinical features of rotavirus infection among pediatric patients in East Java, Indonesia during 2015-2018: dynamic changes in rotavirus genotypes from equine-Like G3 to typical human G1/G3. Front Microbiol. 2019;10:940.
  • Donato CM, Cowley D, Snelling TL, et al. Characterization of a G1P[8] rotavirus causing an outbreak of gastroenteritis in the Northern Territory, Australia, in the vaccine era. Emerg Microbes Infect. 2014;3(7):e47.
  • Hull JJ, Teel EN, Kerin TK, et al. United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction. Pediatr Infect Dis J. 2011;30(1 Suppl):S42–7.
  • Pitzer VE, Bilcke J, Heylen E, et al. Did large-scale vaccination drive changes in the circulating rotavirus population in Belgium? Sci Rep. 2015;5(18585). DOI:https://doi.org/10.1038/srep18585
  • Kotloff KL, Nataro JP, Blackwelder WC, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet. 2013;382(9888):209–222.
  • Praharaj I, Platts-Mills JA, Taneja S, et al. Diarrheal etiology and impact of coinfections on rotavirus vaccine efficacy estimates in a clinical trial of a monovalent human-bovine (116E) oral rotavirus vaccine, Rotavac, India. Clin Infect Dis. 2019;69(2):243–250.
  • Mokomane M, Tate JE, Steenhoff AP, et al. Evaluation of the influence of gastrointestinal coinfections on rotavirus vaccine effectiveness in Botswana. Pediatr Infect Dis J. 2018;37(3):e58–e62.
  • Taniuchi M, Platts-Mills JA, Begum S, et al. Impact of enterovirus and other enteric pathogens on oral polio and rotavirus vaccine performance in Bangladeshi infants. Vaccine. 2016;34(27):3068–3075.
  • Valentini D, Vittucci AC, Grandin A, et al. Coinfection in acute gastroenteritis predicts a more severe clinical course in children. Eur J Clin Microbiol Infect Dis. 2013;32(7):909–915.
  • Moyo SJ, Kommedal Ø, Blomberg B, et al. Comprehensive analysis of prevalence, epidemiologic characteristics, and clinical characteristics of monoinfection and coinfection in diarrheal diseases in children in Tanzania. Am J Epidemiol. 2017;186(9):1074–1083.
  • Bhavnani D, Goldstick JE, Cevallos W, et al. Synergistic effects between rotavirus and coinfecting pathogens on diarrheal disease: evidence from a community-based study in northwestern Ecuador. Am J Epidemiol. 2012;176(5):387–395.
  • Vasco G, Trueba G, Atherton R, et al. Identifying etiological agents causing diarrhea in low income Ecuadorian communities. Am J Trop Med Hyg. 2014;91(3):563–569.
  • Brown EM, Sadarangani M, Finlay BB. The role of the immune system in governing host-microbe interactions in the intestine. Nat Immunol. 2013;14(7):660–667.
  • Jamieson AM. Influence of the microbiome on response to vaccination. Hum Vaccin Immunother. 2015;11(9):2329–2331.
  • Subramanian S, Huq S, Yatsunenko T, et al. Persistent gut microbiota immaturity in malnourished Bangladeshi children. Nature. 2014;510(7505):417–421.
  • Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature. 2012;486(7402):222–227.
  • Guaraldi F, Salvatori G. Effect of breast and formula feeding on gut microbiota shaping in newborns. Front Cell Infect Microbiol. 2012;2(94). DOI:https://doi.org/10.3389/fcimb.2012.00094
  • Jost T, Lacroix C, Braegger CP, et al. New insights in gut microbiota establishment in healthy breast fed neonates. PLOS ONE. 2012;7(8):e44595.
  • Penders J, Thijs C, Vink C, et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics. 2006;118(2):511–521.
  • Tasnim N, Abulizi N, Pither J, et al. Linking the gut microbial ecosystem with the environment: does gut health depend on where we live? Front Microbiol. 2017;8(1935). DOI:https://doi.org/10.3389/fmicb.2017.01935
  • Tickell KD, Atlas HE, Walson JL. Environmental enteric dysfunction: a review of potential mechanisms, consequences and management strategies. BMC Med. 2019;17(1):181.
  • Vlasova AN, Takanashi S, Miyazaki A, et al. How the gut microbiome regulates host immune responses to viral vaccines. Curr Opin Virol. 2019;37:16–25.
  • Iturriza-Gómara M, Cunliffe NA. The Gut Microbiome as Possible Key to Understanding and Improving Rotavirus Vaccine Performance in High–Disease Burden Settings. J Infect Dis. 2017;215(1):8–10.
  • Magwira CA, Taylor MB. Composition of gut microbiota and its influence on the immunogenicity of oral rotavirus vaccines. Vaccine. 2018;36(24):3427–3433.
  • Korpe PS, Petri WA Jr. Environmental enteropathy: critical implications of a poorly understood condition. Trends Mol Med. 2012;18(6):328–336.
  • Lin A, Bik EM, Costello EK, et al. Distinct distal gut microbiome diversity and composition in healthy children from Bangladesh and the United States. PLOS ONE. 2013;8(1):e53838.
  • Harris VC, Armah G, Fuentes S, et al. Significant correlation between the infant gut microbiome and rotavirus vaccine response in rural Ghana. J Infect Dis. 2017;215(1):34–41.
  • Harris V, Ali A, Fuentes S, et al. Rotavirus vaccine response correlates with the infant gut microbiota composition in Pakistan. Gut Microbes. 2018;9(2):93–101.
  • Desselberger U. The Mammalian intestinal microbiome: composition, interaction with the immune system, significance for vaccine efficacy, and potential for disease therapy. Pathogens. 2018;7(3):3.
  • Becker-Dreps S, Vilchez S, Bucardo F, et al. The association between fecal biomarkers of environmental enteropathy and rotavirus vaccine response in Nicaraguan infants. Pediatr Infect Dis J. 2017;36(4):412–416.
  • Naylor C, Lu M, Haque R, et al. Environmental enteropathy, oral vaccine failure and growth faltering in infants in Bangladesh. EBioMedicine. 2015;2(11):1759–1766.
  • Uchiyama R, Chassaing B, Zhang B, et al. Antibiotic treatment suppresses rotavirus infection and enhances specific humoral immunity. J Infect Dis. 2014;210(2):171–182.
  • Harris VC, Haak BW, Handley SA, et al. Effect of antibiotic-mediated microbiome modulation on rotavirus vaccine immunogenicity: a human, randomized-control proof-of-concept trial. Cell Host Microbe. 2018;24(2):197–207.
  • Valdez Y, Brown EM, Finlay BB. Influence of the microbiota on vaccine effectiveness. Trends Immunol. 2014;35(11):526–537.
  • Aliabadi N, Antoni S, Mwenda JM, et al. Global impact of rotavirus vaccine introduction on rotavirus hospitalisations among children under 5 years of age, 2008-16: findings from the Global Rotavirus Surveillance Network. Lancet Glob Health. 2019;7(7):e893–e903.
  • Desselberger U. Potential of plasmid only based reverse genetics of rotavirus for the development of next-generation vaccines. Curr Opin Virol. 2020;44:1–6.